Connection

Wonhwa Lee to Pandemics

Back to Details
This is a "connection" page, showing publications Wonhwa Lee has written about Pandemics.
Wonhwa Lee
Connection Strength
0.028
Pandemics
  1. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 11 17; 5(1):267.
    View in: PubMed
    Score: 0.008
  2. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther. 2020 09 03; 5(1):186.
    View in: PubMed
    Score: 0.008
  3. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia. Sci Adv. 2020 07; 6(31).
    View in: PubMed
    Score: 0.007
  4. Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients. J Korean Med Sci. 2020 Jun 29; 35(25):e234.
    View in: PubMed
    Score: 0.002
  5. Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea. J Korean Med Sci. 2020 Jun 15; 35(23):e209.
    View in: PubMed
    Score: 0.002
  6. Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study. Yonsei Med J. 2020 May; 61(5):431-437.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.